Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|November 14, 2013
Nitric oxide activation of guanylate cyclase pushes the α1 signaling helix and the β1 heme-binding domain closer to the substrate-binding siteMareike Busker, Inga Neidhardt, Sönke Behrends
Biochemical Pharmacology|November 21, 2017
BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugsAnne Sömmer, Peter Sandner, Sönke Behrends
British Journal of Pharmacology|July 24, 2026
sGC stimulator BAY 41-8543 improves survival and ventricular function in a rat model of doxorubicin-induced cardiomyopathy with nephrotic syndromeOlga Gawrys, Petra Škaroupková, Soňa Kikerlová, et al.
Biochemical and Biophysical Research Communications|April 12, 2002
BAY 41-2272 activates two isoforms of nitric oxide-sensitive guanylyl cyclaseMarkus Koglin, Johannes-Peter Stasch, Sönke Behrends
Biochemical Pharmacology|February 13, 2019
A novel soluble guanylyl cyclase activator, BR 11257, acts as a non-stabilising partial agonist of sGCChristin Elgert, Anne Rühle, Peter Sandner, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 8, 2020
Thermal shift assay: Strengths and weaknesses of the method to investigate the ligand-induced thermostabilization of soluble guanylyl cyclaseChristin Elgert, Anne Rühle, Peter Sandner, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patientsRegina Corbalán, Nicolas Chatauret, Sönke Behrends, et al.
European Journal of Pharmacology|May 25, 2020
Tyrosine 135 of the β1 subunit as binding site of BAY-543: Importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugsAnne Rühle, Christin Elgert, Michael G Hahn, et al.
Pageof 4